Posters and talks

  • Immune responses following intrapleural administration of the oncolytic HSV SEPREHVIR in patients with malignant pleural mesothelioma

    Conference: 14th Annual CIMT Meeting (Cancer Immunotherapy)
    Date: 11/05/2016

    Presenter(s): Kirsty Learmonth, Lynne Braidwood, Penella Woll, Chelsea Bolyard, Balveen Kaur, Kevin Blyth and Joe Conner

    Download PDF: CIMT 2016 MPM print

  • SEPREHVIR enhances efficacy of T cell checkpoint inhibition in solid tumor models by increasing T cell recruitment and remodeling the immunosuppressive microenvironment (Talk)

    Conference: 14th Annual CIMT Meeting (Cancer Immunotherapy)
    Date: 11/05/2016

    Presenter(s): Chun-Yu Chen, Pin-Yi Wang, Brian Hutzen, Les Sprague, Hayley Swain, Kellie Haworth, Julia Love, Joe Conner and Timothy Cripe

    Download PDF: CIMT 2016 Dr Cripe's Talk

  • SEPREHVIR enhances GD-2 directed CAR-T cell therapy in GD-2 expressing solid tumor model

    Conference: 14th Annual CIMT Meeting (Cancer Immunotherapy)
    Date: 10/05/2016

    Presenter(s): Kellie Haworth, Samuel Haile, Crystal Mackall, Joe Conner and Timothey Cripe

    Download PDF: CIMT 2016 CAR-T print

  • SEPREHVIR enhances efficacy of T cell checkpoint inhibition in solid tumor models (poster)

    Conference: 14th Annual CIMT Meeting (Cancer Immunotherapy)
    Date: 10/05/2016

    Presenter(s): Chun-Yu Chen, Pin-Yi Wang, Brian Hutzen, Les Sprague, Hayley Swain, Kellie Haworth, Julia Love, Joe Conner and Timothy Cripe

    Download PDF: CIMT 2016 PD-1 print

  • Checkpoint Blockade Enhances Oncolytic Herpes Virotherapy in Immunosuppressive Sarcoma Models

    Conference: AACR's Advances in Pediatric Cancer Research
    Date: 16/11/2015

    Presenter(s): Chun-Yu Chen, Pin-Yi Wang, Brian Hutzen, Kellie Haworth, Joe Conner, and Timothy Cripe

    Download PDF: AACR2015(Checkpoint Blockade and SEPREHVIR combination)

  • Immune responses following intrapleural administration of oncolytic HSV SEPREHVIR in patients with malignant pleural mesothelioma

    Conference: Society for Immunotherapy of Cancer (SITC)
    Date: 06/11/2015

    Presenter(s): Kirsty Learmonth, Lynne Braidwood, Penella Woll and Joe Conner

    Download PDF: SITC2015 (immune responses to SEPREHVIR in mesothelioma)

  • Use of magnetic resonance targeting to steer OV-loaded macrophages to tumor sites in vivo

    Conference: Society for Immunotherapy of Cancer (SITC)
    Date: 06/11/2015

    Presenter(s): Munitta Muthana, Emer Murphy, Aneurin J Kennerley, Russell Hughes, Joe Conner, Fiona Wright, Mark F. Lythgoe, Jon Dobson, Jim M Wild & Claire Lewis

    Download PDF: SITC2015 (OV-loaded macrophages)

  • Cytokine responses following intrapleural administration of oncolytic HSV SEPREHVIR in patients with malignant pleural mesothelioma

    Conference: International Cancer Immunotherapy Conference
    Date: 18/09/2015

    Presenter(s): Kirsty Learmonth, Lynne Braidwood, Penella Woll and Joe Conner

    Download PDF: ICIC2015 (cytokine responses)

  • Evaluation of attenuated HSV1716(SEPREHVIR) in combination with chimeric antigen receptor T cells for solid tumors

    Conference: International Cancer Immunotherapy Conference
    Date: 18/09/2015

    Presenter(s): Samuel T. Haile, Joe Conner, and Crystal L. Mackall

    Download PDF: ICIC2015 (SEPREHVIR in combination with CAR T cells)

  • Development of a Trojan horse oncolytic virotherapy for treatment of myeloma

    Conference: Oncolytic Virus Conference, Boston 2015 (OVC 2015)
    Date: 13/06/2015

    Presenter(s): Simon Tazzyman, Munitta Muthana, Jack Harrison, Claire Lewis, Joe Conner, Andrew Chantry

    Download PDF: OVC2015 (trojan horse)

  • Oncolytic Herpes Simplex Virus Induces PD-L1 Expressing Myeloid Infiltration In Immunocompetent Murine Models Of Neuroblastoma

    Conference: Oncolytic Virus Conference, Boston 2015 (OVC 2015)
    Date: 13/06/2015

    Presenter(s): Chun-Yu Chen, Pin-Yi Wang, Hayley Swain, Brian Hutzen, Mark Currier, Joe Conner, Rimas Orentas, and Timothy Cripe

    Download PDF: OVC2015 (oHSV induces PD-L1)

  • Alisertib Enhances Oncolytic SEPREHVIR Virus Infection and Antitumor Efficacy in Preclinical MPNST and Neuroblastoma Xenograft Models

    Conference: Oncolytic Virus Conference, Boston 2015 (OVC 2015)
    Date: 13/06/2015

    Presenter(s): Mark Currier, Tilat Rizvi, Brooke Nartker, Duo Chen, Chun-Yu Chen, Pin-Yi Wang, Ami Patel, Katherine Chaney, Keri Streby, Balveen Kaur, Paola Grandi, Joseph Glorioso, E. Antonio Chiocca, Jeff Ecsedy, Joe Conner, Nancy Ratner and Timothy Cripe

    Download PDF: OVC2015 (Alisertib and SEPREHVIR combination)

  • Neutralisation effects of pleural fluids do not predict the persistence of the oncolytic HSV SEPREHVIR following intrapleural administration in patients with malignant pleural mesothelioma

    Conference: Oncolytic Virus Conference, Boston 2015 (OVC 2015)
    Date: 13/06/2015

    Presenter(s): Kirsty Learmonth, Lynne Braidwood, Penella Woll and Joe Conner

    Download PDF: OVC 2015(pleural fluids)